Citigroup Lowers Bristol-Myers Squibb (NYSE:BMY) to Neutral

Sedang Trending 1 minggu yang lalu

Citigroup trim Bristol-Myers Squibb from a "buy" standing to a "neutral" standing and lowered their value target for nan institution from $75.00 to $55.00 successful a study connected Friday.

This communicative appeared connected marketbeat.com, 2024-10-25 11:48:48.

Sumber Syndicate
Syndicate